BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36282044)

  • 21. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.
    Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNPS1 functions as an oncogenic splicing factor in cervical cancer cells.
    Deka B; Chandra P; Yadav P; Rehman A; Kumari S; Kunnumakkara AB; Singh KK
    IUBMB Life; 2023 Jun; 75(6):514-529. PubMed ID: 36300671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
    Zhang Y; Xu W; Wang Y; Li J; He G; Guan M; Zeng X; Bian W; Song Y; Liu J
    Bioengineered; 2022 Mar; 13(3):5962-5974. PubMed ID: 35184675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA helicase DDX5-induced circPHF14 promotes gastric cancer cell progression.
    Wang J; Han C; Wang J; Peng Q
    Aging (Albany NY); 2023 Mar; 15(7):2525-2540. PubMed ID: 36996491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
    Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
    Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
    Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H3 is spliced by SRSF3 in colorectal cancer.
    Zhang C; Chen Y; Li F; Yang M; Meng F; Zhang Y; Chen W; Wang W
    Cancer Immunol Immunother; 2021 Feb; 70(2):311-321. PubMed ID: 32719950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H; Xie Z; Tang G; Wei S; Chen G
    J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
    Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
    Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression.
    Zhou L; Guo J; Jia R
    Biochem Biophys Res Commun; 2019 Feb; 509(4):966-972. PubMed ID: 30654935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors.
    Che Y; Fu L
    J Cancer; 2020; 11(12):3502-3511. PubMed ID: 32284746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
    Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
    Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
    Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.
    Han BY; Liu Z; Hu X; Ling H
    Cell Death Dis; 2022 Nov; 13(11):940. PubMed ID: 36347834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Qin K; Jian D; Xue Y; Cheng Y; Zhang P; Wei Y; Zhang J; Xiong H; Zhang Y; Yuan X
    Oncol Rep; 2021 Mar; 45(3):1213-1225. PubMed ID: 33650667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
    Guo J; Jia J; Jia R
    Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
    Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
    Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.